MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts

  • ID: 3754724
  • Report
  • Region: Global
  • 157 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Abbott Vascular
  • Biotronik
  • Boston Scientific
  • C.R. Bard
  • Cook Medical
  • Cordis (Cardinal Health)
  • MORE
MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts

Summary

The peripheral vascular interventions market is a dynamic, billion-dollar market with solid growth potential through 2022. The rising prevalence of peripheral artery disease (PAD) combined with the increasing endovascular procedure rate will ensure that the market will continue to expand in the coming years. Recent technological advancements within this space, including drug-eluting stents and balloons, bioabsorbable stents (BAS), and polytetrafluoroethylene (PTFE)-covered stents have the potential to revolutionize the future of PAD treatment, as these devices provide improved solutions for complex pathologies.

The technologies covered in this report include lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents. This report focuses on the global peripheral vascular interventions market in North America (Canada, Mexico, US), Europe (France, Germany, Italy, Spain, Russia, UK), Asia-Pacific (APAC) (Australia, China, India, Japan, South Korea), and South America (Brazil). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different technologies.

Highlights

Key Questions Answered

- What is the current and future peripheral vascular interventions market outlook in the developed and emerging markets? What trends are affecting the global market?
- Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with the current generation of devices? How will emerging technologies fulfill these unmet needs?
- What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for peripheral vascular interventions?
- What are the challenges that have hindered widespread adoption of newer technologies?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global peripheral vascular interventions market?

Scope

- Overview of recent key industry events and analysis of their market impact.
- Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2022.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
- Analysis of the current and future market competition in the global peripheral vascular interventions market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading vascular surgeons, interventional cardiologists, and interventional radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Vascular
  • Biotronik
  • Boston Scientific
  • C.R. Bard
  • Cook Medical
  • Cordis (Cardinal Health)
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Catalyst

2.2 Related Reports

3 Market Access

3.1 Reimbursement Trends

3.1.1 North America

3.1.2 Europe

3.1.3 Asia-Pacific

3.1.4 South America

3.2 Mergers and Acquisitions/Key Partnerships

4 Unmet Needs and Market Opportunity Analysis

4.1 High Quality Data for Drug-eluting Balloons in Specific Indications

4.2 Minimizing Periprocedural Stroke Risk During Carotid Artery Interventions

4.2.1 Anti-thrombotic Coatings

4.2.2 Occlusion with Flow Reversal

4.2.3 Integrated Embolic Protection

4.3 Motorized Delivery Systems

4.4 Reducing Reintervention Rates

4.4.1 Controlled Drug Delivery Mechanisms

4.4.2 Improving Physician Training in Endovascular Techniques

5 Competitive Assessment

5.1 Market Share Analysis

5.1.1 North America

5.1.2 Europe

5.1.3 Asia-Pacific

5.1.4 South America

5.2 Key Companies and Product Profiles

5.2.1 Abbott Vascular

5.2.2 Biotronik

5.2.3 Boston Scientific

5.2.4 C.R. Bard

5.2.5 Cook Medical

5.2.6 Cordis (Cardinal Health)

5.2.7 Medtronic

5.2.8 Terumo

5.2.9 W.L. Gore

5.2.10 Other Players

5.3 Pipeline Products Assessment

6 Market Outlook

6.1 Procedure Trends

6.1.1 Treatment Paradigm

6.1.2 Lower Extremity Revascularization

6.1.3 Carotid Artery Stenting

6.1.4 Renal Artery Stenting

6.2 Global Market Drivers and Barriers

6.2.1 Driver: Rising Disease Prevalence

6.2.2 Driver: Rising Endovascular Procedure Rates

6.2.3 Driver: Improved Solutions for Superficial Femoral Artery Revascularization

6.2.4 Driver: Development of Low-profile Delivery Systems

6.2.5 Driver: Reduced Stent Fracture Rates with Second Generation Stents

6.2.6 Barrier: Impact of Current Reimbursement Schemes

6.2.7 Barrier: Lack of Rigorous Clinical Trials for Peripheral Bioabsorbable Stents

6.3 Market Outlooks by Segment

6.3.1 Global Overview

6.3.2 Lower Extremity Stents

6.3.3 Percutaneous Transluminal Angioplasty Balloons

6.3.4 Carotid Stents

6.3.5 Renal Stents

6.4 Market Outlooks by Geography

6.4.1 Global Overview

6.4.2 North America

6.4.3 Europe

6.4.4 Asia-Pacific

6.4.5 South America

7 Appendix

7.1 Bibliography

7.2 Abbreviations

7.3 Methodology

7.3.1 Overview

7.3.2 Coverage

7.3.3 Secondary Research

7.4 Forecasting Methodology

7.5 Physicians and Specialists Included in This Study

7.5.1 Key Opinion Leaders

7.6 Primary Research Summary

7.7 About the Authors

7.7.1 Analysts

7.7.2 Global Head of Medical Devices

7.7.3 About us

7.8 Disclaimer

1.1 List of Tables

Table 1: Medicare National Average of Inpatient Hospital Reimbursement for Peripheral Vascular Interventions, 2015-2016

Table 2: Hospital Outpatient Reimbursement for Peripheral Vascular Interventions, 2015

Table 3: Key Mergers, Acquisitions, and Partnerships in Peripheral Vascular Interventions Market

Table 4: Abbott Vascular - Company SWOT Analysis

Table 5: Abbott Vascular - Marketed Products Assessment

Table 6: Abbott Vascular - Clinical Trials to Watch

Table 7: Biotronik - Company SWOT Analysis

Table 8: Biotronik - Marketed Products Assessment

Table 9: Biotronik - Clinical Trials to Watch

Table 10: Boston Scientific - Company SWOT Analysis

Table 11: Boston Scientific - Marketed Products Assessment

Table 12: Boston Scientific - Clinical Trials to Watch

Table 13: C.R. Bard - Company SWOT Analysis

Table 14: C.R. Bard - Marketed Products Assessment

Table 15: C.R. Bard - Clinical Trials to Watch

Table 16: Cook Medical - Company SWOT Analysis

Table 17: Cook Medical - Marketed Products Assessment

Table 18: Cook Medical - Clinical Trials to Watch

Table 19: Cordis (Cardinal Health) - Company SWOT Analysis

Table 20: Cordis (Cardinal Health) - Marketed Products Assessment

Table 21: Cordis (Cardinal Health) - Clinical Trials to Watch

Table 22: Medtronic - Company SWOT Analysis

Table 23: Medtronic - Marketed Products Assessment

Table 24: Medtronic - Clinical Trials to Watch

Table 25: Terumo - Company SWOT Analysis

Table 26: Terumo - Marketed Products Assessment

Table 27: Terumo - Clinical Trials to Watch

Table 28: W.L. Gore - Company SWOT Analysis

Table 29: W.L. Gore - Marketed Products Assessment

Table 30: W.L. Gore - Clinical Trials to Watch

Table 31: Other Players Assessment

Table 32: Other Clinical Trials to Watch

Table 33: Pipeline Products Assessment

Table 34: Global Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Table 35: Global Lower Extremity Stents Market Forecast ($m), 2012-2022

Table 36: Global PTA Balloons Market Forecast ($m), 2012-2022

Table 37: Global Carotid Stents Market Forecast ($m), 2012-2022

Table 38: Global Renal Stents Market Forecast ($m), 2012-2022

Table 39: Global Peripheral Vascular Interventions Market Forecast ($m), by Country, 2012-2022

Table 40: North America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Table 41: Europe Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Table 42: Asia-Pacific Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Table 43: South America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

1.2 List of Figures

Figure 1: North America Market Shares for Lower Extremity Stents, by Company, 2015

Figure 2: North America Market Shares for Standard PTA Balloons, by Company, 2015

Figure 3: North America Market Shares for PTA DEB, by Company, 2015

Figure 4: North America Market Shares for Carotid Stents, by Company, 2015

Figure 5: Europe Market Shares for Lower Extremity Stents, by Company, 2015

Figure 6: Europe Market Shares for Standard PTA Balloons, by Company, 2015

Figure 7: Europe Market Shares for PTA DEB, by Company, 2015

Figure 8: Europe Market Shares for Carotid Stents, by Company, 2015

Figure 9: APAC Market Shares for Lower Extremity Stents, by Company, 2015

Figure 10: APAC Market Shares for Standard PTA Balloons, by Company, 2015

Figure 11: APAC Market Shares for Standard PTA DEB, by Company, 2015

Figure 12: APAC Market Shares for Carotid Stents, by Company, 2015

Figure 13: South America Market Shares for Lower Extremity Stents, by Company, 2015

Figure 14: South America Market Shares for PTA Balloons, by Company, 2015

Figure 15: South America Market Shares for PTA DEB, by Company, 2015

Figure 16: South America Market Shares for Carotid Stents, by Company, 2015

Figure 17: Treatment Modalities - PAD

Figure 18: Global Procedure Volume Forecast for Stenting in the Lower Extremity, by Artery, 2012-2022

Figure 19: Global Procedure Volume Forecast for Standard Balloon Angioplasty in the Lower Extremity, by Artery, 2012-2022

Figure 20: Global Procedure Volume Forecast for DEB Angioplasty in the Lower Extremity, by Artery, 2012-2022

Figure 21: Endovascular Treatment Patterns in the Iliac Arteries, by Region, 2015

Figure 22: Endovascular Treatment Patterns in the Femoropopliteal Arteries, by Region, 2015

Figure 23: Endovascular Treatment Patterns in the Infrapopliteal Arteries, by Region, 2015

Figure 24: Global Procedure Volume Forecast for Carotid Artery Stenting, 2012-2022

Figure 25: Global Procedure Volume Forecast for Renal Artery Stenting, 2012-2022

Figure 26: Global Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Figure 27: Global Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022

Figure 28: Global Lower Extremity Stents Market Forecast ($m), 2012-2022

Figure 29: Lower Extremity Stents Market Comparison, by Segment, 2015 and 2022

Figure 30: Global PTA Balloons Market Forecast ($m), 2012-2022

Figure 31: Global Carotid Stents Market Forecast ($m), 2012-2022

Figure 32: Global Renal Stents Market Forecast ($m), 2012-2022

Figure 33: Global Peripheral Vascular Interventions Market Forecast ($m), by Country, 2012-2022

Figure 34: Global Peripheral Vascular Interventions Market Comparison, by Country, 2015 and 2022

Figure 35: North America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Figure 36: North America Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022

Figure 37: Europe Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Figure 38: Europe Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022

Figure 39: APAC Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Figure 40: APAC Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022

Figure 41: South America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

Figure 42: South America Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022

Figure 43: Peripheral Vascular Survey Primary Research Participants, by Country
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Abbott Vascular
Biotronik
Boston Scientific
C.R. Bard
Cook Medical
Cordis (Cardinal Health)
Medtronic
Terumo
W.L. Gore
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll